4
Changes in Ownership
Cardiff Oncology, Inc. Filed Acc 0000950170-24-137938
Chief Financial Officer bought 7,716 shares at an average $4.76 ($36,726)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Levine James E. Chief Financial Officer | 2024-12-16 | Purchase | +2,564 | $3.83 | $9,820 | 62,564 | I |
| Levine James E. Chief Financial Officer | 2024-12-17 | Purchase | +2,752 | $5.42 | $14,905 | 65,316 | I |
| Levine James E. Chief Financial Officer | 2024-12-18 | Purchase | +2,400 | $5.00 | $12,000 | 67,716 | I |
| Open-market purchases · 7,716 sh · avg $4.76 · $36,726 | |||||||
Loading xslF345X05/ownership.xml…